{"name":"Shanghai Life Science & Technology","slug":"shanghai-life-science-technology","ticker":"","exchange":"","domain":"","description":"Shanghai Life Science & Technology is a biotechnology company focused on the development of innovative stem cell therapies. The company's lead product is a human umbilical cord mesenchymal stem cell injection, currently in Phase 1 clinical trials.","hq":"","founded":0,"employees":"N/A","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Human umbilical cord mesenchymal stem cell injection","genericName":"Human umbilical cord mesenchymal stem cell injection","slug":"human-umbilical-cord-mesenchymal-stem-cell-injection","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"Human umbilical cord mesenchymal stem cell injection","genericName":"Human umbilical cord mesenchymal stem cell injection","slug":"human-umbilical-cord-mesenchymal-stem-cell-injection","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxQcU1EVWd5RHM1ai1FMDBzNjUxY2s5enQwbFNjLTR0T29uR2JFVWV0RFRIX2t0SmYwcHp3VG9RYlZaTE9jc0tUblFYTURUeVNWaUZGQnJHOENFaWo3ZmxBY2h0WUVEQ3pJV01YdWJGUHdETnZlcFU2aDdnUXJNSmVVdEdMRm5jS25ob0QtVXFacW1rd2ZISmI0cHhIaTZDMW1yRmxvQ3p3?oc=5","date":"2026-03-19","type":"pipeline","source":"Fierce Pharma","summary":"UPDATED: AstraZeneca to build cell therapy manufacturing hub, R&D center in Shanghai - Fierce Pharma","headline":"UPDATED: AstraZeneca to build cell therapy manufacturing hub, R&D center in Shanghai","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi8gJBVV95cUxQem1QNkZoLXZKWURKcEVVRTVKMjJ1aTJuMHU2RVJQMTBJN012RTkzbnMtU0FsYkZPOTc4elhjWjJ2OHk3VjZvZDdkdTZfVnIwQ0FGbHNGZVRpUmI3M29XM041ZFhXeS1TMzJVd2lpZ3RkTEU5Rk9NYnhwd0tYcnpkcTFyYkJERHdRUHdRek05T0wzU2lmY3lwUW1CM1pYY1VIRjcxUFdzNXV1aHdSZW82MEljYjg0NFFYbEFSQTJXMWNDSXJjT0UwOWJONkxtUTNoZWlEY1VZWHl0c000NGcyLWxGd0RQdURFWnVweDBYTWNYbndfVU9Od2laVXVUZzJmdG03dFRvbVRVNE1maVdFWG5PbmxGMzRIODdKb0NrSlE3a24xUlQ0N3o2ZFNHbVhyOEN3d2tZZ3BZeHozVVhLYTBaY1kxVWpXV09wc0NOREhQRG92T3Q2RkplOFlqMUkxejFrOWlGNDRVRUJJRVpuU3dB?oc=5","date":"2026-03-12","type":"pipeline","source":"GlobeNewswire","summary":"Pharmaceutical and Biotechnology Royalty Rates Agreements - GlobeNewswire","headline":"Pharmaceutical and Biotechnology Royalty Rates Agreements","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijAFBVV95cUxNdlhGY0UwZTN1UXVGQzQtZmx1TUpCWkZmcVhHRzZVcWpRcUhrYUVLMjVYZThrc1UyZTcyXzZscFlOV190Qk42eGdEaFRRU3g5bHVvSkxHbmdzQzZJT0RLb1pTbGdIall5ZlRudEdTb0ZtaERDUUo2bDJfb2ZRQjBNcGFKcEM0UEZTdnh4Vw?oc=5","date":"2026-02-19","type":"pipeline","source":"TargetJobs","summary":"Paid Internship in China: Biology, Chemical & Medicine - TargetJobs","headline":"Paid Internship in China: Biology, Chemical & Medicine","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxQZ1A1eEpiYWhrTFBLcTE4RXA5VmlyZlZ0aDFleUpFd2o1eklNQmd6ZE9PNlVHeENlT0dVdi1qQ3c5MXROc0gxemRXWW5uOE54UmFfQnFaSkwya1dWRFBUTGVsdUVDcUNiaURmbUJKakkxTVZGVUpKMTVRSzF1RkppYnZuY1JZRFR5cGRlTUVzeVJyUmo0bWg5eUF6SmU2YXhLSkNRQnUxVGY?oc=5","date":"2026-01-21","type":"pipeline","source":"Forbes","summary":"How China Became the Biotech Industry’s Back-Office - Forbes","headline":"How China Became the Biotech Industry’s Back-Office","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxPQ0IyRmpWZzhoSnhlMVFEdVdtRzM2TjRtN0FfSXp5YjBSMHJVcGZwNlJxR09OODhWQWhIM3NRcV9pdEczQUhiaEs1aXpXYVlRWFlWb1k5QVVfd0t5bmQxRmVGblpDZVM4SmRtN2taaExmRU9KN3BmLU95bVRRM1V4aWtYaEZQVGpZNzRsOEVrSTdVc2FiVTFDcDJhb19DczA5M2IzM0FR?oc=5","date":"2025-12-09","type":"pipeline","source":"BioWorld News","summary":"73 Chinese biotech, med-tech companies file for HK IPOs in 2025 - BioWorld News","headline":"73 Chinese biotech, med-tech companies file for HK IPOs in 2025","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizwFBVV95cUxOVWZ3eEpJaWU4bGhKUjE5d1BtcjdaSHlacVk3UkxzQ053bDhHYnE5eVNGdEptZUpaZzNZWXNLOG80SkNWdGZENkFJc0pIdElwM1F3LUI3blh0bHpJVEh3VnRKYkFwX1p0YzF6aGpnSTZfX21vZVhLaWd3RFNaNllKSUQ4X2UzaDNkeDAyUnpzVWtjblZrLU9kTXpGcm83cS02M2tVYlF0V19XX3lMZDNKR0hqY3NhNGhVbEt1czc2M2wtNThGRVY5V0pwelI3aTQ?oc=5","date":"2025-10-17","type":"pipeline","source":"NutraIngredients.com","summary":"Sirio Pharma sets up longevity lab in Shanghai, products to launch later this year - NutraIngredients.com","headline":"Sirio Pharma sets up longevity lab in Shanghai, products to launch later this year","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxOZGJJVFVwaHBHRG82bThjbEZnbTUwbDJXWXZtbW9QdHR1YXkzWUJIanlxcXNxcS1JeUxYVFFDdV95Z1AyQjAzdnVCNWtTbnhfS05SVlZVWW1MTXR0eU9Pc0JIa3lIeVBId2xIc08wUFJuRWFFcGF2U3BXNlI1aktYdU1VdGRURnk1ZXVkOUxrSXVDcDItQlB3eDlnN1NfclFTSFM3MkZWd3Q?oc=5","date":"2025-09-05","type":"pipeline","source":"C&EN","summary":"In the rise of Chinese biotech, some see opportunity. Others see a threat - C&EN","headline":"In the rise of Chinese biotech, some see opportunity. Others see a threat - C&EN","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTFBVS1YwVGJNVlkxeDFiNVk1MkFleXNyUzlXQzdjZG10UTFfQnVac3JfVzFTVzdqUTlMeDlaWUJacDhHcG5qSXdsWTNnRnN3UjJIVloyQzJyQ0JhQndOVWFzVUVhaWI4NzBHUVAxMEdn?oc=5","date":"2025-08-17","type":"pipeline","source":"The New York Times","summary":"Opinion | China’s Biotech Is Cheaper and Faster Than America’s - The New York Times","headline":"Opinion | China’s Biotech Is Cheaper and Faster Than America’s","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxOY2Q0ek9hOGI3V2VKaXo3VnRHLW0zeUhiNDliWkgxbnhpbDRDMV9aUFhPS21SRXdIcW04djlxb2RPV296SUJseUhOa0xZd1ZzdTRhRXd5MUVObUxwTExUVFlHaVlUWHZxM2RFTTIzR2tPYUVGd0xfRWtKMjRqTEx6d3d3MHowUUMw?oc=5","date":"2025-07-09","type":"regulatory","source":"CHEManager","summary":"IMCD Opens New Life Science Hub in Shanghai - CHEManager","headline":"IMCD Opens New Life Science Hub in Shanghai","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxQZDJ6Zk54ckFkZElrSEVJc0hESVQyUDlValc2VjJiWnlwM2JyOTMtMk1mQ1BrNlBZTWVzaHNlQ2JyX2tuUnhCYXhwd2Q1WFVXdkxFQW9kZmNmbGpOSDZKczJDNzRDNFoxdkhSU1N6MEdEWjRsZWFDR1Y0Y2JxeXhiYTIyYzVRZ0xs?oc=5","date":"2025-04-24","type":"pipeline","source":"Mercator Institute for China Studies (MERICS)","summary":"Lab leader, market ascender: China's rise in biotechnology - Mercator Institute for China Studies (MERICS)","headline":"Lab leader, market ascender: China's rise in biotechnology - Mercator Institute for China Studies (MERICS)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxNcm51ZFUtR2NRSWNOa0pFZWpzYzNMQ0Q3aUxJSGFUazFWc1pfYjJ3Um40RU1XRlVsTjFXaFpLZTZFOWNfYUtBR3dxV3YtRmthSmw0TUdkR2pXVXhuR3V0UGw2Y2xHX1VnZ3otNDlOSW5QaTVvWTRuaHRlZU1abll4V0gtRk80clgtUUdTN202T1FqSGFENnZkOA?oc=5","date":"2025-03-31","type":"trial","source":"JLL","summary":"Life Science Industrial Park - development in Shanghai - JLL","headline":"Life Science Industrial Park - development in Shanghai","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE1TVkN0MmZZNzd5Q3FXcVgxQkRVVXJXaFpnWVk2NHhudUpZU1A2dU5RdE9IUU9jN2Mtc3lXT0tIa2NzaVFfY1VrdUJQMlRMaVMzOWdfZVlRdU5XOHVraTZz?oc=5","date":"2024-03-01","type":"pipeline","source":"Nature","summary":"The upward trajectory of China’s ‘Silicon Valley’ for the life sciences - Nature","headline":"The upward trajectory of China’s ‘Silicon Valley’ for the life sciences","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_1":1},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}